8UG1 | pdb_00008ug1

Crystal structure of KHK-C and compound 13


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.99 Å
  • R-Value Free: 
    0.205 (Depositor), 0.209 (DCC) 
  • R-Value Work: 
    0.173 (Depositor), 0.177 (DCC) 
  • R-Value Observed: 
    0.174 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8UG1

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor.

Durham, T.B.Hao, J.Spinazze, P.Stack, D.R.Toth, J.L.Massey, S.Mbofana, C.T.Johnston, R.D.Lineswala, J.P.Wrobleski, A.Minguez, J.M.Perez, C.Smith, D.L.Lamar, J.Leon, R.Corkins, C.Durbin, J.Tung, F.Guo, S.Linder, R.J.Yumibe, N.Wang, W.MacKrell, J.Antonellis, M.Mascaro, B.

(2023) J Med Chem 66: 15960-15976

  • DOI: https://doi.org/10.1021/acs.jmedchem.3c01410
  • Primary Citation Related Structures: 
    8UG1, 8UG3

  • PubMed Abstract: 

    The identification of clinical candidate LY3522348 (compound 23 ) is described. LY3522348 is a highly selective, oral dual inhibitor of human ketohexokinase isoforms C and A (hKHK-C, hKHK-A). Optimization began with highly efficient ( S )-2-(2-methylazetidin-1-yl)-6-(1 H -pyrazol-4-yl)-4-(trifluoromethyl)nicotinonitrile ( 3 ). Efforts focused on developing absorption, distribution, metabolism, potency, and in vitro safety profiles to support oral QD dosing in patients. Structure-based design leveraged vectors for substitution of the pyrazole ring, which provided an opportunity to interact with several different proximal amino acid residues in the protein. LY3522348 displayed a robust pharmacodynamic response in a mouse model of fructose metabolism and was advanced into clinical trials.


  • Organizational Affiliation
    • Discovery Chemistry Research and Technology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States.

Macromolecule Content 

  • Total Structure Weight: 70.36 kDa 
  • Atom Count: 4,999 
  • Modeled Residue Count: 603 
  • Deposited Residue Count: 630 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Ketohexokinase
A, B
315Homo sapiensMutation(s): 0 
Gene Names: KHK
EC: 2.7.1.3
UniProt & NIH Common Fund Data Resources
Find proteins for P50053 (Homo sapiens)
Explore P50053 
Go to UniProtKB:  P50053
PHAROS:  P50053
GTEx:  ENSG00000138030 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP50053
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
WNH
(Subject of Investigation/LOI)

Query on WNH



Download:Ideal Coordinates CCD File
C [auth A],
H [auth B]
{(2R)-1-[(4M)-4-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-6-(trifluoromethyl)pyrimidin-2-yl]azetidin-2-yl}methanol
C17 H21 F3 N6 O
KXGFTHNEKPQMOG-CYBMUJFWSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
D [auth A]
E [auth A]
F [auth A]
I [auth B]
J [auth B]
D [auth A],
E [auth A],
F [auth A],
I [auth B],
J [auth B],
K [auth B],
L [auth B],
M [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
GOL

Query on GOL



Download:Ideal Coordinates CCD File
G [auth A],
N [auth B],
O [auth B]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.99 Å
  • R-Value Free:  0.205 (Depositor), 0.209 (DCC) 
  • R-Value Work:  0.173 (Depositor), 0.177 (DCC) 
  • R-Value Observed: 0.174 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 82.583α = 90
b = 86.793β = 90
c = 136.432γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
SCALAdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2023-12-06
    Type: Initial release
  • Version 1.1: 2023-12-27
    Changes: Database references